4.8 Letter

Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Candidate gene analysis of 21n22: Support for S100B as a susceptibility gene for bipolar affective disorder x with psychosis

S. Roche et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)

Article Biochemistry & Molecular Biology

Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly

J-C Lambert et al.

MOLECULAR PSYCHIATRY (2007)

Article Clinical Neurology

Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment

Ash Sarandol et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)

Article Neurosciences

Evidence for a wide extra-astrocytic distribution of S100B in human brain

Johann Steiner et al.

BMC NEUROSCIENCE (2007)

Article Biochemistry & Molecular Biology

SNPs and haplotypes in the S100B gene reveal association with schizophrenia

JX Liu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Letter Biochemistry & Molecular Biology

Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF

M Rothermundt et al.

MOLECULAR PSYCHIATRY (2004)

Article Clinical Neurology

Glia as a putative target for antidepressant treatments

H Manev et al.

JOURNAL OF AFFECTIVE DISORDERS (2003)